Analogs of thalidomide as potential angiogenesis inhibitors
Details for Australian Patent Application No. 2002306596 (hide)
International Classifications
Event Publications
19 December 2002 Complete Application Filed
Priority application(s): 60/271,941 27.02.01 US
6 March 2003 Application Open to Public Inspection
Published as AU-B-2002306596
30 October 2003 Amendment Made
The nature of the amendment is: Amend the name of the applicant from The Government of the United States of America, the Secretary of the Department of Health and Human Services to The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services
3 June 2004 Corrigenda
Amendments, Section 104 - Amendments Made Under the name The Government of the U.S.A. as rep. by the Secretary of the Department of Health and Human Services, under the application No. 2002306596 correct the name to read The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services
17 January 2008 Application Accepted
Published as AU-B-2002306596
15 May 2008 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2002306597-DISTRIBUTED VERIFICATION, CONFIRMATION OR DELAY TIME SYSTEM AND METHOD
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser